Preformulation development of recombinant pegylated staphylokinase SY161 using statistical design
about
Monitoring manufacturing process yields, purity and stability of structural variants of PEGylated staphylokinase mutant SY161 by quantitative reverse-phase chromatography.Product development issues for PEGylated proteins.On translation of antibody drug conjugates efficacy from mouse experimental tumors to the clinic: a PK/PD approach.Design expert supported mathematical optimization and predictability study of buccoadhesive pharmaceutical wafers of Loratadine.
P2860
Preformulation development of recombinant pegylated staphylokinase SY161 using statistical design
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Preformulation development of ...... SY161 using statistical design
@en
Preformulation development of ...... SY161 using statistical design
@nl
type
label
Preformulation development of ...... SY161 using statistical design
@en
Preformulation development of ...... SY161 using statistical design
@nl
prefLabel
Preformulation development of ...... SY161 using statistical design
@en
Preformulation development of ...... SY161 using statistical design
@nl
P2093
P2860
P356
P1433
P1476
Preformulation development of ...... SY161 using statistical design
@en
P2093
Frank Bedu-Addo
Randall Moreadith
Siddharth J Advant
P2860
P356
10.1208/PS040419
P577
2002-01-01T00:00:00Z